Category: Co-Sponsored

An expert panel of two ophthalmologists will explore how anti-angiogenesis agents can help reduce treatment burden faced by patients while achieving optimal vision outcomes.

Join an expert panel consisting of an ophthalmologist and an optometrist to discuss the burden and causes of DED, the role of the lacrimal functional unit (LFU) in DED pathophysiology, and the rationale for targeted neuromodulation. The panel will also explore the symptoms of DED and the new pharmacologic agents that target the LFU, along with clinical evidence supporting their use.

Eye care specialists examine the causes and potential solutions to barriers that create inequities in diabetic eye care, from screening to treatment.